A multiplex qPCR assay for transgenes detection: A novel approach for gene doping control in horseracing using conventional laboratory setup
Drug Testing and Analysis · 2023
DOI: 10.1002/dta.3483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2023. Verfasst von Kin-Sing Wong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China. Hauptthemen laut MEDLINE: Doping in Sports, Erythropoietin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Illicit administration of transgene into horses is a form of gene doping that has been a key concern in equine sports. The large number of potential performance‐enhancing transgenes has demanded a cost‐effective and reliable detection method. Multiplex qPCR is a relevant technique, but the cross‐talking between fluorophores and high background noise limits the method sensitivity and specificity. This study reports a simpler multiplexing approach by using the same fluorophore for four hydrolysis probes each targeting one of the four transgenes: human growth hormone, insulin‐like growth factor 1, equine erythropoietin and interleukin‐10. Any positive findings from this multiplex qPCR assay can then be confirmed by individual qPCR assays to identify potential transgene(s). This has effectively eliminated the cross‐talking issue and allowed an improved signal‐to‐noise than conventional multiplex qPCR assay. It has also removed the limitation imposed by the available choice of fluorophores and optical channels of qPCR instruments on the number of transgenes that can be analysed in a multiplex qPCR assay. This novel multiplex qPCR has been successfully validated. The estimated limits of detection were ~1500–2500 copies/mL of blood, thus demonstrating comparable sensitivity with the corresponding duplex qPCR assays. Concurring results were obtained by analysing hundreds of official blood samples provided by racehorses with this multiplex qPCR assay and the accredited individual duplex qPCR assays. This novel multiplex qPCR assay for detecting multiple transgenes is a cost‐effective screening method using a conventional laboratory setup and has opened up the potential to include the testing of additional transgenes in a single assay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
ORCID-Profile: Kin-Sing Wong, Hiu Wing Cheung, Terence S M Wan, Emmie N M Ho
Zitieren
APA
Wong, K. S., Cheung, H. W., Szeto, C. W. L., Tsang, C. Y. N., Wan, T. S. M., & Ho, E. N. M. (2023). A multiplex qPCR assay for transgenes detection: A novel approach for gene doping control in horseracing using conventional laboratory setup. Drug Testing and Analysis. https://doi.org/10.1002/dta.3483
Vancouver
Wong KS, Cheung HW, Szeto CWL, Tsang CYN, Wan TSM, Ho ENM. A multiplex qPCR assay for transgenes detection: A novel approach for gene doping control in horseracing using conventional laboratory setup. Drug Testing and Analysis. 2023. doi:10.1002/dta.3483
BibTeX
@article{Wong2023,
author = {Wong, Kin-Sing and Cheung, Hiu Wing and Szeto, Cherry W L and Tsang, Candice Y N and Wan, Terence S M and Ho, Emmie N M},
title = {A multiplex qPCR assay for transgenes detection: A novel approach for gene doping control in horseracing using conventional laboratory setup},
journal = {Drug Testing and Analysis},
year = {2023},
doi = {10.1002/dta.3483}
}
EUVIMED